|
Video: What is a Stock Split?
|
|
Immune Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development and commercialization of targeted therapeutics in the fields of immuno-inflammation, dermatology and immuno-oncology. Co.'s primary product candidate, bertilimumab, is a human antibody, which targets eotaxin-1, a key regulator of immuno-inflammation. NanoCyclo is a topical nanocapsule formulation of cyclosporine-A, for the treatment of atopic dermatitis and psoriasis. Co.'s pain programs also include AmiKet / AmiKet Nano, a prescription topical analgesic cream, and LidoPAIN, an adhesive-backed, lidocaine-based patch for the treatment of lower back pain. According to our IMNP split history records, IMNP has had 1 split. | |
|
IMNP (IMNP) has 1 split in our IMNP split history database. The split for IMNP took place on April 13, 2017. This was a 1 for 20 reverse split, meaning for each 20 shares of IMNP owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.
When a company such as IMNP conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the IMNP split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into IMNP shares, starting with a $10,000 purchase of IMNP, presented on a split-history-adjusted basis factoring in the complete IMNP split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
01/02/2019 |
|
Start price/share: |
$89.80 |
|
End price/share: |
$0.01 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.99% |
|
Average Annual Total Return: |
-85.57% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1.12 |
|
Years: |
4.70 |
|
|
|
Date |
Ratio |
04/13/2017 | 1 for 20 |
|
|